186 related articles for article (PubMed ID: 32571273)
1. Expression of epithelial-Mesenchymal transition related markers in Plasmacytoid Urothelial carcinoma of the urinary bladder.
Nomura S; Suzuki Y; Akatsuka J; Endo Y; Shimizu A; Hamasaki T; Kimura G; Kondo Y
BMC Urol; 2020 Jun; 20(1):72. PubMed ID: 32571273
[TBL] [Abstract][Full Text] [Related]
2. [Plasmacytoid urothelial carcinoma of the urinary bladder: a clinicopathologic study of 16 cases].
Zhang W; Jiang YX; Liu Y; Yu WJ; Zhao H; Li YJ
Zhonghua Bing Li Xue Za Zhi; 2013 Jul; 42(7):433-7. PubMed ID: 24246859
[TBL] [Abstract][Full Text] [Related]
3. Epithelial-To-Mesenchymal Transition and Its Correlation With Clinicopathologic Features in Patients With Urothelial Carcinoma of the Bladder.
Singh R; Ansari JA; Maurya N; Mandhani A; Agrawal V; Garg M
Clin Genitourin Cancer; 2017 Apr; 15(2):e187-e197. PubMed ID: 27601277
[TBL] [Abstract][Full Text] [Related]
4. Plasmacytoid urothelial carcinoma of the urinary bladder: a clinical pathological study and literature review.
Wang Z; Lu T; Du L; Hu Z; Zhuang Q; Li Y; Wang CY; Zhu H; Ye Z
Int J Clin Exp Pathol; 2012; 5(6):601-8. PubMed ID: 22949945
[TBL] [Abstract][Full Text] [Related]
5. Plasmacytoid urothelial carcinoma of the urinary bladder: a case report and immunohistochemical study.
Sato K; Ueda Y; Kawamura K; Aihara K; Katsuda S
Pathol Res Pract; 2009; 205(3):189-94. PubMed ID: 19041193
[TBL] [Abstract][Full Text] [Related]
6. Krüppel-like factor 4 is a novel prognostic predictor for urothelial carcinoma of bladder and it regulates TWIST1-mediated epithelial-mesenchymal transition.
Tseng WC; Chuang CW; Yang MH; Pan CC; Tarng DC
Urol Oncol; 2016 Nov; 34(11):485.e15-485.e24. PubMed ID: 27519276
[TBL] [Abstract][Full Text] [Related]
7. Plasmacytoid Urothelial Carcinoma of the Urinary Bladder: A Clinicopathologic and Immunohistochemical Analysis of 49 Cases.
Fox MD; Xiao L; Zhang M; Kamat AM; Siefker-Radtke A; Zhang L; Dinney CP; Czerniak B; Guo CC
Am J Clin Pathol; 2017 May; 147(5):500-506. PubMed ID: 28371875
[TBL] [Abstract][Full Text] [Related]
8. Plasmacytoid/diffuse urothelial carcinoma: a single-institution immunohistochemical and molecular study of 69 patients.
Perrino CM; Eble J; Kao CS; Whaley RD; Cheng L; Idrees M; Hashemi-Sadraei N; Monn MF; Kaimakliotis HZ; Bandali E; Grignon D
Hum Pathol; 2019 Aug; 90():27-36. PubMed ID: 31054897
[TBL] [Abstract][Full Text] [Related]
9. E-cadherin expression in plasmacytoid, signet ring cell and micropapillary variants of urothelial carcinoma: comparison with usual-type high-grade urothelial carcinoma.
Lim MG; Adsay NV; Grignon DJ; Osunkoya AO
Mod Pathol; 2011 Feb; 24(2):241-7. PubMed ID: 20818341
[TBL] [Abstract][Full Text] [Related]
10. Sarcomatoid Urothelial Carcinoma of the Bladder: Analysis of 28 Cases With Emphasis on Clinicopathologic Features and Markers of Epithelial-to-Mesenchymal Transition.
Sanfrancesco J; McKenney JK; Leivo MZ; Gupta S; Elson P; Hansel DE
Arch Pathol Lab Med; 2016 Jun; 140(6):543-51. PubMed ID: 27031776
[TBL] [Abstract][Full Text] [Related]
11. Epithelial-mesenchymal transformation markers E-cadherin and survivin predict progression of stage pTa urothelial bladder carcinoma.
Breyer J; Gierth M; Shalekenov S; Aziz A; Schäfer J; Burger M; Denzinger S; Hofstädter F; Giedl C; Otto W
World J Urol; 2016 May; 34(5):709-16. PubMed ID: 26394624
[TBL] [Abstract][Full Text] [Related]
12. WHO 1973 grade 3 and infiltrative growth pattern proved, aberrant E-cadherin expression tends to be of predictive value for progression in a series of stage T1 high-grade bladder cancer after organ-sparing approach.
Otto W; Breyer J; Herdegen S; Eder F; Bertz S; May M; Mayr R; Lausenmeyer EM; Denzinger S; van Rhijn BW; Burger M; Hartmann A
Int Urol Nephrol; 2017 Mar; 49(3):431-437. PubMed ID: 28035618
[TBL] [Abstract][Full Text] [Related]
13. Expression profile of epithelial-mesenchymal transition markers in non-muscle-invasive urothelial carcinoma of the bladder: correlation with intravesical recurrence following transurethral resection.
Liu B; Miyake H; Nishikawa M; Fujisawa M
Urol Oncol; 2015 Mar; 33(3):110.e11-8. PubMed ID: 25262382
[TBL] [Abstract][Full Text] [Related]
14. Plasmacytoid urothelial carcinoma of the bladder.
Lopez-Beltran A; Requena MJ; Montironi R; Blanca A; Cheng L
Hum Pathol; 2009 Jul; 40(7):1023-8. PubMed ID: 19297008
[TBL] [Abstract][Full Text] [Related]
15. Plasmacytoid urothelial carcinoma of the bladder.
Qin M; Wang G; Sun Y; He Q
Indian J Pathol Microbiol; 2014; 57(2):320-2. PubMed ID: 24943778
[TBL] [Abstract][Full Text] [Related]
16. Expression of HMGA2 in bladder cancer and its association with epithelial-to-mesenchymal transition.
Ding X; Wang Y; Ma X; Guo H; Yan X; Chi Q; Li J; Hou Y; Wang C
Cell Prolif; 2014 Apr; 47(2):146-51. PubMed ID: 24571540
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of epithelial and mesenchymal cell markers in canine urinary bladder transitional cell carcinoma.
Shinada M; Saeki K; Yoshitake R; Eto S; Tsuboi M; Chambers JK; Uchida K; Kato D; Yoshimoto S; Kamoto S; Ikeda N; Kinoshita R; Fujita N; Nishimura R; Nakagawa T
Vet J; 2020 Dec; 266():105571. PubMed ID: 33323173
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of thymosin β4 in the regulation of epithelial-mesenchymal transformation in urothelial carcinoma.
Wang ZY; Zeng FQ; Zhu ZH; Jiang GS; Lv L; Wan F; Dong R; Xiao XY; Xing SA
Urol Oncol; 2012; 30(2):167-76. PubMed ID: 20864366
[TBL] [Abstract][Full Text] [Related]
19. [Plasmacytoid urothelial carcinoma of the urinary bladder. A study of 7 cases].
Gaafar A; Garmendia M; de Miguel E; Velasco V; Ugalde A; Bilbao FJ; de Petris G; López JI
Actas Urol Esp; 2008 Sep; 32(8):806-10. PubMed ID: 19013979
[TBL] [Abstract][Full Text] [Related]
20. Plasmacytoid urothelial carcinoma of the bladder: histological and clinical features of 5 cases.
Fritsche HM; Burger M; Denzinger S; Legal W; Goebell PJ; Hartmann A
J Urol; 2008 Nov; 180(5):1923-7. PubMed ID: 18801525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
